mefenamic acid and piroxicam

mefenamic acid has been researched along with piroxicam in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19904 (18.18)18.7374
1990's3 (13.64)18.2507
2000's3 (13.64)29.6817
2010's10 (45.45)24.3611
2020's2 (9.09)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Gozalbes, R; Pineda-Lucena, A1
Ekins, S; Williams, AJ; Xu, JJ1
Kumar, M; Sinha, VR; Thareja, S1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Haig, G1
Serfaty, D1
Kawai, T; Ogawa, N; Ohnishi, M1
Court, H; Volans, GN1
Curti, C; Jordani, MC; Mingatto, FE; Santos, AC; Uyemura, SA1
Curti, C; Mingatto, FE; Pigoso, AA; Rodrigues, T; Santos, AC; Uyemura, SA1
Bracht, A; Ishii-Iwamoto, EL; Kelmer-Bracht, AM; Lopez, CH; Sampaio, E; Yamamoto, NS1
Bouajila, J; Boyer, A; Couderc, F; Ibrahim, H; Nepveu, F1
Au, AL; Chan, SW; Kwan, YW; Lee, SM; Leung, GP; Li, RW; Seto, SW; Tse, CM1
Abbaspourrad, A; Arshadi, M; Dinari, M; Mokhtari, N; Taymouri, S1
Ammar, H; Aouam, K; Ben Fadhel, N; Ben Fredj, N; Ben Romdhane, H; Chaabane, A; Chadli, Z1

Reviews

2 review(s) available for mefenamic acid and piroxicam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Cross-reactivity between nonsteroidal anti-inflammatory drugs in fixed drug eruption: Two unusual cases and a literature review.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Humans; Mefenamic Acid; Middle Aged; Naproxen; Piroxicam; Retrospective Studies

2023

Trials

3 trial(s) available for mefenamic acid and piroxicam

ArticleYear
A double-blind comparison of mefenamic acid and piroxicam in acute soft tissue injuries.
    Current medical research and opinion, 1988, Volume: 10, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Female; Humans; Male; Mefenamic Acid; Middle Aged; Pain; Piroxicam; Sprains and Strains; Wounds and Injuries

1988
A comparative crossover study of piroxicam vs. mefenamic acid and diclofenac in France.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1986, Volume: 138

    Topics: Adult; Clinical Trials as Topic; Diclofenac; Dysmenorrhea; Female; Humans; Mefenamic Acid; Piroxicam

1986
Double-blind comparison of piroxicam and mefenamic acid in the treatment of oral surgical pain.
    European journal of rheumatology and inflammation, 1983, Volume: 6, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mefenamic Acid; Middle Aged; Mouth; Pain, Postoperative; Piroxicam; Thiazines

1983

Other Studies

17 other study(ies) available for mefenamic acid and piroxicam

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
QSAR-based solubility model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19

    Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
    European journal of medicinal chemistry, 2012, Volume: 53

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Poisoning after overdose with non-steroidal anti-inflammatory drugs.
    Adverse drug reactions and acute poisoning reviews, 1984,Spring, Volume: 3, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Child; Child, Preschool; Diflunisal; Female; Fenoprofen; Feprazone; Humans; Ibuprofen; Indomethacin; Ketoprofen; London; Male; Mefenamic Acid; Naproxen; Oxyphenbutazone; Phenylbutazone; Piroxicam; Thiazines; Tolmetin

1984
In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis.
    Archives of biochemistry and biophysics, 1996, Oct-15, Volume: 334, Issue:2

    Topics: Acetaminophen; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Dipyrone; Kidney Cortex; Kinetics; Male; Mefenamic Acid; Mitochondria; Oxidative Phosphorylation; Oxygen Consumption; Piroxicam; Rats; Rats, Wistar; Uncoupling Agents

1996
Influence of nonsteroidal anti-inflammatory drugs on calcium efflux in isolated rat renal cortex mitochondria and aspects of the mechanisms involved.
    The international journal of biochemistry & cell biology, 1998, Volume: 30, Issue:9

    Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Cyclosporine; Diclofenac; Dipyrone; Ibuprofen; In Vitro Techniques; Ion Transport; Kidney Cortex; Male; Mefenamic Acid; Mitochondria; NAD; NADP; Oxidation-Reduction; Piroxicam; Rats; Rats, Wistar; Salicylic Acid

1998
The action of flufenamic acid and other nonsteroidal anti-inflammatories on sulfate transport in the isolated perfused rat liver.
    General pharmacology, 1999, Volume: 32, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Dose-Response Relationship, Drug; Flufenamic Acid; In Vitro Techniques; Liver; Male; Mefenamic Acid; Naproxen; Niflumic Acid; Perfusion; Piroxicam; Rats; Rats, Wistar; Sulfates; Sulfonamides; Sulfur Radioisotopes; Time Factors

1999
Determination of non-steroidal anti-inflammatory drugs in pharmaceuticals and human serum by dual-mode gradient HPLC and fluorescence detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Sep-15, Volume: 857, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Monitoring; Humans; Mefenamic Acid; Molecular Structure; Naproxen; Pharmaceutical Preparations; Piroxicam; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Serum; Spectrometry, Fluorescence; Tablets

2007
Inhibitory effect of nonsteroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells.
    European journal of pharmacology, 2009, Jun-10, Volume: 612, Issue:1-3

    Topics: Adenosine; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Cell Proliferation; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Etodolac; Humans; Indomethacin; Inhibitory Concentration 50; Ketoprofen; Kinetics; Mefenamic Acid; Muscle, Smooth, Vascular; Piroxicam; Sulindac; Temperature; Tetrazolium Salts; Thiazoles; Thioinosine

2009
Covalent polybenzimidazole-based triazine frameworks: A robust carrier for non-steroidal anti-inflammatory drugs.
    Materials science & engineering. C, Materials for biological applications, 2020, Volume: 108

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Carbon Dioxide; Drug Carriers; Kinetics; Mefenamic Acid; Nanoparticles; Piroxicam; Polymers; Porosity; Solubility; Spectroscopy, Fourier Transform Infrared; Temperature; Triazines; X-Ray Diffraction

2020